Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 5
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Robaeys, Geert Arain, Amber and Stöver, Heino 2017. Emerging Issues in Prison Health.

    Marco, Andrés Antón, José J. Saiz de la Hoya, Pablo de Juan, José Faraco, Inmaculada Caylà, Joan A. and Trujols, Joan 2015. Personality disorders among Spanish prisoners starting hepatitis C treatment: Prevalence and associated factors. Psychiatry Research, Vol. 230, Issue. 3, p. 749.

    Sequera, Víctor-Guillermo Valencia, Salomé García-Basteiro, Alberto L Marco, Andrés and Bayas, José M 2015. Vaccinations in prisons: A shot in the arm for community health. Human Vaccines & Immunotherapeutics, Vol. 11, Issue. 11, p. 2615.

    Hatzakis, A. Van Damme, P. Alcorn, K. Gore, C. Benazzouz, M. Berkane, S. Buti, M. Carballo, M. Cortes Martins, H. Deuffic-Burban, S. Dominguez, A. Donoghoe, M. Elzouki, A-N. Ben-Alaya Bouafif, N. Esmat, G. Esteban, R. Fabri, M. Fenton, K. Goldberg, D. Goulis, I. Hadjichristodoulou, T. Hatzigeorgiou, T. Hamouda, O. Hasurdjiev, S. Hughes, S. Kautz, A. Malik, M. Manolakopoulos, S. Matičič, M. Papatheodoridis, G. Peck, R. Peterle, A. Potamitis, G. Prati, D. Roudot-Thoraval, F. Reic, T. Sharara, A. Shennak, M. Shiha, G. Shouval, D. Sočan, M. Thomas, H. Thursz, M. Tosti, M. Trépo, C. Vince, A. Vounou, E. Wiessing, L. and Manns, M. 2013. The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference. Journal of Viral Hepatitis, Vol. 20, p. 1.

    Tresó, Bálint Barcsay, Erzsébet Tarján, Anna Horváth, Gergely Dencs, Ágnes Hettmann, Andrea Csépai, Mária Magdolna Győri, Zoltán Rusvai, Erzsébet and Takács, Mária 2012. Prevalence and Correlates of HCV, HVB, and HIV Infection among Prison Inmates and Staff, Hungary. Journal of Urban Health, Vol. 89, Issue. 1, p. 108.


Viral hepatitis B, C and HIV infection in Croatian prisons

  • V. BUREK (a1), J. HORVAT (a2), K. BUTORAC (a3) and R. MIKULIĆ (a1)
  • DOI:
  • Published online: 05 March 2010

Incarcerated persons comprise about 0·4% of the Croatian population, of whom 25–30% misuse drugs. We attempted to determine the structure of the prison population, prevalence of HBV, HCV, HIV markers, co-infections with HBV, HCV and HIV and acute HBV, HCV and HIV infection. In total, 25·9% of prisoners were positive for some markers for viral hepatitis (HBV 11·3%, HCV 8·3%, HBV/HCV 6·3%). Prevalence of HBV infection in intravenous drug users (IDUs) was 26·2% (highly promiscuous group 20·4%, individuals with psychiatric diseases and personality disorders 16·0%). HCV infection in IDUs was 52·0% and 4·9% in the highly promiscuous group. HBV/HCV co-infection was registered in 34·9% of prisoners positive for HBV markers (203/582). Acute HBV infection was detected in 0·5%, and HCV in 1·2%. Only 0·15% (5/3348) of prisoners were anti-HIV positive. It appears that individuals with psychiatric diseases and personality disorders could be an additional risk population for these viral infections.

Corresponding author
*Author for correspondence: Dr V. Burek, University Hospital for Infectious Diseases, Zagreb, Mirogojska 8, Croatia. (Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1.V Lesnikar . Epidemiology of hepatitis B and C in Croatia. Acta Medica Croatica 2005; 59: 371381.

4.M Malliori , A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction 1998; 93: 243251.

6.K Dolan , W Hall , A Wodak .The provision of methadone within prison settings. In: J Ward , RP Mattick , W Hall , eds. Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Amsterdam: Harwood Academic, 1998, pp. 379395.

7.A Rodella , Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B. Journal of Clinical Virology 2006; 37: 206212.

8.J Long , Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrance to Irish prisons: a national cross sectional survey. British Medical Journal 2001; 323: 16.

9.V Tefanova , T Tallo , K Kutsar . Urgent action needed to stop spread of hepatitis B and C in Estonia. Eurosurveillance 2006; 11(4).

10.S Babudieri , Correlates of HIV, HBV, and HCV infections in prison inmate population: results from a multicentre study in Italy. Journal of Medical Virology 2005; 76: 311317.

11.J Pallas , Risk factors for monoinfections and coinfections with HIV, hepatitis B and hepatitis C viruses in northern Spanish prisoners. Epidemiology and Infection 1999; 123: 95–102.

12.FA Drobniewski , Tuberculosis, HIV seroprevalence and intravenous drug abuse in prisoners. European Respiratory Journal 2005; 26: 298304.

13.T Butler , The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey. Australian and New Zealand Journal of Public Health 2008; 31: 4450.

14.PB Cristensen , Prevalence and incidence of bloodborne viral infections among Danish prisoners. European Journal of Epidemiology 2000; 16: 10431049.

15.AR Weild , Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Communicable Disease and Public Health 2000; 3: 121126.

17.M Rotily , HBV and HIV screening, and hepatitis B immunization programme in the prison of Marseille, France. International Journal of STD and AIDS 1997; 8: 753759.

19.P Turpeinen , Drug abuse and viral hepatitis among psychiatric admissions to a Finnish psychiatric emergency ward. Nordic Journal of Psychiatry 1999; 53: 141145.

22.S Allwright , Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of the national cross sectional survey. British Medical Journal 2000; 321: 7882.

23.CM Weinbaum , KM Sabin , SS Santibanez . Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS 2005; 19 (Suppl. 3): S41S46.

25.SM Gore , Prevalence of hepatitis C in prisons: WASH-C surveillance link to self-reported risk behaviours. Quarterly Journal of Medicine 1999; 92: 2532.

28.T Butler , Seroprevalence of markers for hepatitis B, C and G in male and female prisoners – NSW 1996. Australian and New Zealand Journal of Public Health 1999; 23: 377385.

29.FM Averhoff , Occupational exposures and risk of hepatitis B virus infection among public safety workers. Journal of Occupational and Environmental Medicine 2002; 44: 591596.

33.TI Michalak , TNQ Pham , PM Mulrooney-Cousins . Molecular diagnosis of occult HCV and HBV infection. Future Virology 2007; 2: 451465.

35.TM Hammett . HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response. American Journal of Public Health 2006; 96: 974978.

37.S Mrani , Occult HBV infection may represent a major risk factor of non-responsive to anti-viral therapy of chronic hepatitis C. Journal of Medical Virology 2007; 79: 10751081.

38.PB Christensen , Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule. Vaccine 2004; 22: 38973901.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *